Web Watch
Web Watch in One Page
The verdict on Yatsen is "Watchlist," and that watch resolves through a small number of dated, observable events over the next four to six months. The investment case lives or dies on five questions: (1) does the S&M ratio finally bend below the 66% line in the 2026 quarterly prints; (2) does the founder-affiliated March 2026 convertible become a known liability — terms closed, NDRC certificate received — or remain a pending overhang; (3) do Proya, Mao Geping and Yunnan Botanée annex the premium-skincare lane before Galenic, DR.WU and Eve Lom can claim it; (4) do Yatsen brands break into a Tmall or JD top-10 skincare ranking at 618 or Double 11; and (5) does 90.7% founder voting control translate into more related-party flow, more independent-director departures, or both. The five monitors below are tuned to those five questions — nothing more.
Active Monitors
| Rank | Watch item | Cadence | Why it matters | What would be detected |
|---|---|---|---|---|
| 1 | YSG quarterly earnings prints and material 6-K disclosures | 1 day | Each release publishes the S&M ratio, operating cash flow, skincare-segment mix and cash balance — the four lines on which the bull and bear cases disagree | Q1/Q2/Q3 2026 results press releases, conference-call transcripts, and 6-K filings with current-period revenue, S&M, OCF, inventory days or segment-mix detail |
| 2 | Founder-affiliated convertible terms and NDRC foreign-debt certificate | 1 day | Closing terms, NDRC approval and tranche-2 economics reframe the convertible from "pending dilution overhang" to "known liability" — the single largest unpriced item | First Note / Second Note tranche closings, NDRC certificate receipts, holder-put exercises, anti-dilution adjustments, or any new founder- or Trustar-Capital-affiliated financing |
| 3 | Premium-skincare moves by Proya, Mao Geping and Yunnan Botanée | 1 week | Same domestic wallet, same Tmall/Douyin shelf — these three peers decide whether Galenic, DR.WU and Eve Lom earn the multiple their gross margin implies | New clinical or premium-skincare SKU launches, Tmall/Douyin flagship-store openings, KOL exclusivity deals or quarterly commentary that directly overlap Yatsen skincare brands |
| 4 | 618 and Double 11 channel rankings on Tmall, JD and Douyin | 1 day | A Tmall or JD top-10 skincare slot for any Yatsen brand would invalidate the structural channel-asymmetry bear case; continued absence locks the discount | Syntun briefs, platform-published top-10 brand lists and Jing Daily / Beauty Tap commentary that name or omit Perfect Diary, Galenic, DR.WU or Eve Lom |
| 5 | Governance, insider activity and related-party transactions | 1 week | 90.7% founder voting control plus rising related-party purchases is the structural discount — any new director departure or new RP counterparty widens it | Independent-director resignations, audit-chair changes, Form 3/4/5 filings, Class B → Class A conversions, or new related-party purchase counterparties disclosed in interim 6-Ks |
Why These Five
The verdict's "what would change the view" list ranks two prints above everything else: the H1 2026 S&M ratio together with trailing-four-quarter operating cash flow, and the closing terms of the founder-affiliated March 2026 convertible. Monitors 1 and 2 catch those directly and at the cadence at which they will appear. Monitor 3 watches the three peers — Proya, Mao Geping and Yunnan Botanée — that the competition tab flagged as the highest-severity threats to the skincare pivot; their product, pricing and channel moves shape the S&M-line answer one quarter before YSG itself reports. Monitor 4 captures the only piece of independent third-party evidence that can break or confirm the structural channel-asymmetry bear case during the 618 (mid-June) and Double 11 (early November) festival windows. Monitor 5 watches the governance side, which sits behind both the discount the equity already carries and the rising related-party-purchase line disclosed in the FY2025 20-F. Everything else — sell-side coverage, technicals, M&A speculation — is downstream of these five.